UNSPSC 51341605: Somantadine hydrochloride

This classification denotes an antiviral agent with the molecular formula C14H25N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I505KI9F8Q, chemically known as 2-(1-adamantyl)-1,1-dimethylethylamin hydrochlorid but more generally known as somantadine hydrochloride, which bears US NIH Compound Identifier 3033453. Most nations, for tariff and trade purposes, schedule somantadine hydrochloride under HS 29213099 and SITC 51453. As of Q4 2014, SOMANTADINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Somantadine hydrochloride bears US NLM identifiers UMLS ID C2825701 and NCI Concept Code C81610. SMILES: CC(C)(C[C@]12C[C@@H]3C[C@H](C1)CC(C3)C2)N.CL.

UNSPSC 51341605 Somantadine hydrochloride is a Commodity code that designates a specific pharmaceutical active ingredient, but recent state and local opportunities show little relevant procurement activity under this code's nominal scope. The two most recent opportunities posted under this code—an Illinois Department of Public Health piggyback pharmaceutical contract awarded to Chartwell Rx LLC in August 2026 and a Seminole County, Florida procurement for naloxone and drug deactivation systems posted in June 2026—neither involve somantadine hydrochloride. The Illinois contract supplies doxycycline hyclate and ciprofloxacin hydrochloride tablets totaling $2,999,999.11 over three years; the Seminole County procurement seeks naloxone units and safe drug deactivation systems on an annual basis. Both opportunities reflect broader state and local purchasing of pharmaceutical and medical products through competitive bidding and cooperative purchasing consortia, but neither aligns with the code's designation of somantadine hydrochloride specifically.

Geographic activity appears concentrated in the Southeast and Midwest, with recent postings from Florida and Illinois. The Illinois Department of Public Health and Seminole County represent typical issuing bodies—a state health department and a county health authority—both sourcing pharmaceutical supplies for public health and emergency-response use. The mismatch between the code's narrow pharmaceutical designation and the actual goods being solicited suggests the code sees limited state and local procurement volume under its specific scope, or that opportunities are tagged inconsistently with the UNSPSC taxonomy. No open solicitations for somantadine hydrochloride specifically appear in the recent record.